Table 1.
Characteristics of the sample.
| Characteristic | Total (N = 90) | Males (n = 22) | Females (n = 68) | |||
|---|---|---|---|---|---|---|
| N | % | N | % | N | % | |
| 90 | 100.0 | 22 | 24.4 | 68 | 75.6 | |
| Age at the beginning of the survey (years), mean (SD) | 58.72 (12.56) | 55.59 (15.29) | 59.74 (11.48) | |||
| Age at onset (years), mean (SD) | 48.76 (12.15) | 44.23 (13.72) | 50.21 (11.35) | |||
| Disease duration (years), mean (SD) | 9.86 (7.74) | 11.18 (10.74) | 9.43 (6.53) | |||
| Comorbidities | ||||||
| None | 23 | 25.6 | 7 | 31.8 | 16 | 23.5 |
| One | 34 | 37.8 | 8 | 36.4 | 26 | 38.2 |
| Two or more | 33 | 36.7 | 7 | 31.8 | 26 | 38.2 |
| Type of disorder | ||||||
| Dystonia | 72 | 80.0 | 18 | 81.8 | 54 | 79.4 |
| Hemispasm | 18 | 20.0 | 4 | 18.2 | 14 | 20.6 |
| Body distribution | ||||||
| Focal | 78 | 86.7 | 19 | 86.4 | 59 | 86.8 |
| Segmental | 10 | 11.1 | 3 | 13.6 | 7 | 10.3 |
| Multifocal | 1 | 1.1 | 0 | 0.0 | 1 | 1.5 |
| Generalized | 1 | 1.1 | 0 | 0.0 | 1 | 1.5 |
| Type of botulinum toxin | ||||||
| Xeomin | 34 | 37.8 | 10 | 45.5 | 24 | 35.3 |
| Dysport | 56 | 62.2 | 12 | 55.5 | 44 | 64.7 |